Validating cold chain processes for transporting living cell therapies
End to End, Cold Chain Validation Using Sample Attached History Log
This study is all about making sure that special cell therapies, which are taken from patients and changed before being put back in, are kept at the right cold temperatures during shipping so they stay safe and effective for you.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Bio Tillion, LLC NIH-funded |
| Lab location | 1 site (Skillman, United States) |
| Project ID | NIH-10757932 on NIH RePORTER |
What this research studies
This research focuses on ensuring that living cell therapies, which are harvested from patients and modified before being re-injected, are transported under optimal conditions. It aims to validate cold chain practices to maintain ultra-low temperatures during shipping, which is crucial for preserving the integrity of the samples. By using advanced technology to monitor temperature changes throughout the transportation process, the research seeks to prevent damage to these personalized therapies, thereby improving clinical outcomes for patients. The study emphasizes the importance of strict adherence to protocols for freezing, storage, and thawing of these sensitive biological materials.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing regenerative medicine therapies that involve the use of living cells.
Not a fit: Patients who are not receiving regenerative medicine therapies or those whose treatments do not involve the transportation of living cells may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the safety and effectiveness of regenerative medicine therapies for patients.
How similar studies have performed: Other research has shown success in optimizing cold chain logistics for biological samples, indicating that this approach has potential for significant advancements in the field.
Where this research is happening
Skillman, United States
- Bio Tillion, LLC — Skillman, United States (Active)
Researchers
- Principal investigator: Davidowitz, Hananel — Bio Tillion, LLC
- Study coordinator: Davidowitz, Hananel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.